论文部分内容阅读
为了观察水飞蓟降迁延性,慢性病毒性肝炎(简称迁、慢肝)血清谷-丙转氨酶(简称S-GPT)的疗效,我院肝炎门诊于1976年11月至1977年7月间采用北京制药工业研究所制的水飞蓟(益肝灵)共治疗71例迁、慢肝病例,分两组对比,常规治疗组33例(简称Ⅰ组:水飞蓟70毫克,每日3次,连服3个月),加量治疗组38例(简称Ⅱ组:水飞蓟140毫克,每日3次,连服3个月),现将临床观察和分析介绍如
In order to observe the effect of silymarin on deferred ductility and serum glutamic-aminotransferase (abbreviated as S-GPT) in patients with chronic viral hepatitis (referred to as moving and slowing liver), the hepatitis clinic in our hospital was used in Beijing between November 1976 and July 1977. Silymarin (Yi Gan Ling) made by the Pharmaceutical Industry Research Institute co-treated 71 cases of moving and chronic liver, divided into two groups, 33 cases in the conventional treatment group (referred to as group I: silymarin 70 mg, 3 times a day, Even for 3 months), 38 patients in the treatment group were added (referred to as group II: 140 mg of silymarin, 3 times a day for 3 months), and clinical observation and analysis are now introduced.